UMIN ID: C000000185
Registered date:01/01/2006
Clinical significance of micrometastasis of stage II colorectal cancer. A prospective multicenter trial
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Stage II colorectal cancer |
| Date of first enrollment | 2001/11/01 |
| Target sample size | 350 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Randomization in micrometastasis positive cases HCHU 300mg for 1 year Randomization in micrometastasis positive cases No therapy |
Outcome(s)
| Primary Outcome | 3 year-disease free survival when stratified by presense or absence of micrometastasis |
|---|---|
| Secondary Outcome | 5 year-overall survival when stratified by presense or absence of micrometastasis |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | simultaneous or metachrounous cancers multiple cancer lesions |
Related Information
| Primary Sponsor | MCSGO(Multicenter Clinical Study Group of Osaka, Colorectal Cancer Division) |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hirofumi Yamamoto |
| Address | Yamadaoka 2-2, Suita city, Osaka Japan |
| Telephone | 06-6879-3251 |
| hyamamoto@gesurg.med.osaka-u.ac.jp | |
| Affiliation | MCSGO(Multicenter Clinical Study Group of Osaka, Colorectal Cancer Division) Coordinating Office |
| scientific contact | |
| Name | Morito Monden |
| Address | Department of Surgery, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita-City, Osaka 565-0871, Japan Japan |
| Telephone | 0668793251 |
| hyamamoto@gesurg.med.osaka-u.ac.jp | |
| Affiliation | Graduate School of Medicine, Osaka University Department of Surgery |